Viral infections often leave lasting marks on human memory and thinking skills by altering the balance of the immune system. A recent comprehensive review of medical data reveals that specific inflammatory immune responses slow down mental processing and impair memory across a variety of different viral illnesses. These findings were published in the journal Neuroscience & Biobehavioral Reviews.
When a virus invades the body, the immune system launches a defense mechanism that involves an array of cells and chemical messengers. Some of these messengers are known as pro-inflammatory cytokines. These are small proteins that sound the alarm and promote inflammation to clear the infection.
Once the threat passes, the body normally releases anti-inflammatory signals to calm the response and restore normal operations. Sometimes this defensive response does not turn off correctly, leading to lingering systemic inflammation.
Medical professionals routinely observe this phenomenon in people recovering from viruses like the one that causes COVID-19. Patients often report persistent brain fog, which includes trouble concentrating, slowed thinking, and memory lapses. Similar cognitive issues frequently appear in people living with human immunodeficiency virus, herpes, and hepatitis.
Different areas of the brain manage different cognitive tasks. The outer layer of the brain, known as the cortex, handles complex thought processes and memory storage. Other regions deep within the brain, like the basal ganglia, help regulate motor learning and emotional responses.
Historically, the study of how immune activity affects the brain is rooted in a field called psychoneuroimmunology. Early studies established that peripheral immune activation triggers behavioral changes like social withdrawal and fatigue. Researchers refer to this physiological reaction as sickness behavior.
This acute response acts as an early model for anticipating the chronic cognitive deficits observed during prolonged viral infections. In the past, researchers looked at these cognitive problems by studying one specific disease at a time. They also tended to use broad cognitive tests that graded overall brain function rather than specific mental skills.
This fragmented approach made it difficult to see if different viruses triggered the same underlying immune responses in the brain. The emergence of the COVID-19 pandemic renewed global interest in how viral exposures broadly affect specific mental domains. “Our goal was to take a cross-disciplinary approach to move beyond the fragmented perspective that prevails in this field,” explains Julie Péron, an associate professor at the University of Geneva.
To address this gap, a team of researchers sought to map out the shared biological patterns connecting immune activity and brain function. Anthony Nuber-Champier, a doctoral student at the University of Geneva and the Geneva University Hospitals in Switzerland, led the research effort.
Nuber-Champier and his colleagues wanted to look beyond the boundaries of individual diseases. They aimed to identify exact immune markers that corresponded with specific cognitive changes regardless of the underlying viral infection.
To conduct the study, the research team performed a systematic review of the existing medical literature. They initially gathered 931 scientific articles that investigated links between the immune system and cognitive function. They filtered this collection down to 32 highly specific studies that met their strict inclusion criteria.
This final pool of data encompassed more than 25,000 adult patients. The researchers excluded studies involving patients with co-existing conditions like cancer or psychiatric disorders. This step ensured that the observed cognitive changes were directly related to the viral infections and subsequent immune responses.
The included studies covered a wide range of viral infections, including those responsible for COVID-19, human immunodeficiency virus, herpes, and hepatitis. The team extracted data on each patient’s immune markers, which are measurable indicators of immune system activity found in the blood.
They also recorded the results of targeted neuropsychological tests. These tests measured specific mental abilities like episodic memory, which is the ability to recall specific past events. They also tracked processing speed, which is how quickly a person can understand and react to information.
By looking at these varied diseases together, the researchers identified clear biological signatures related to cognitive decline. They found a strong link between persistent inflammation and distinct memory and concentration problems. Certain types of white blood cells known as activated monocytes were associated with negative outcomes.
High levels of these circulating monocytes corresponded with slower processing speeds and reduced mental flexibility. The team noted similar outcomes when they looked at specific chemical messengers. Pro-inflammatory cytokines, including interleukin-6 and tumor necrosis factor, correlated with worsened episodic memory.
High levels of these proteins were also linked to a general slowing of mental processing. Nuber-Champier and his team observed that these inflammatory markers heavily impacted how well patients performed on targeted neurological exams.
Elevated antibody production also signaled potential cognitive troubles in the reviewed data. The researchers found that high levels of Immunoglobulin G, a common type of antibody, negatively impacted memory and attention span. A combined drop in specific defense cells, known as T cells and B cells, predicted similar deficits in attention.
These patterns mirror the biological changes often seen in the brains of very elderly individuals facing cognitive decline. However, not all immune activity was linked to mental decline. The researchers found that certain regulatory immune markers seemed to protect cognitive abilities.
Elevated levels of CD4 T cells, which are white blood cells that help coordinate the immune response, were associated with better mental processing speeds. A specific anti-inflammatory messenger called interleukin-10 consistently supported strong memory and executive function. Executive function refers to the mental skills needed to plan, focus attention, and juggle multiple tasks.
These protective markers highlight the importance of harmony within the body’s defense systems. A finely tuned balance between pro-inflammatory and anti-inflammatory signaling appears essential for optimal cognitive health. “However, immune responses vary from person to person. What appears to be decisive is the balance between these different inflammatory signals in maintaining long-term cognitive stability,” the researcher points out.
While the review provides a broad look at brain-immune interactions, the researchers noted several limitations in the available data. Most of the analyzed studies relied on immune markers taken from peripheral blood samples rather than from cerebrospinal fluid. Cerebrospinal fluid bathes the brain and spinal cord, making it a more direct indicator of central nervous system health.
It is not completely clear if blood markers perfectly reflect the inflammatory activity happening deep inside the brain. The data pool also featured variations in how different studies were designed. Some of the original studies lacked detailed demographic information, such as the educational backgrounds of the participants.
Educational level can influence cognitive reserve, which is the brain’s ability to improvise and find alternate ways of getting a job done. A high cognitive reserve can sometimes mask the early signs of mental decline. Additionally, a large portion of the available data came from research focused specifically on the human immunodeficiency virus.
This heavy reliance on one illness might influence the general applicability of some findings. The researchers also noted that many older studies used basic screening tools that only provided a superficial glance at cognitive health. These simple tests lack the sensitivity needed to capture subtle changes in specific mental domains.
Moving forward, the research team emphasizes the need for more precise and uniform cognitive testing. Future studies should combine detailed psychological evaluations with advanced brain imaging techniques. This approach would help scientists see exactly how systemic inflammation alters specific neural circuits in the brain.
They also suggest investigating how social factors, genetics, and environment influence the immune system’s impact on thinking and memory. Understanding these biological pathways could eventually lead to new medical treatments. Doctors might one day use immune profiles to identify patients at a high risk for accelerated brain aging or dementia. By targeting specific immune imbalances early, healthcare providers could potentially preserve cognitive abilities in patients recovering from viral infections.
The study, “Immune-cognitive relationships across viral infections: A transnosological systematic review,” was authored by Anthony Nuber-Champier, Gautier Bréville, Patrice H. Lalive, Frédéric Assal, and Julie A. Péron.
